Cargando…
Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study
PURPOSE: The use of platelet-rich plasma (PRP) for the treatment of nonhealing ulcers is a relatively new technique. Although it seems to result in a satisfying level of healing and low complication rates, data regarding its effectiveness remain sparse. This study aims to evaluate the potential ther...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Vascular Specialist International
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453601/ https://www.ncbi.nlm.nih.gov/pubmed/30993104 http://dx.doi.org/10.5758/vsi.2019.35.1.22 |
_version_ | 1783409418839261184 |
---|---|
author | Tsachiridi, Maria Galyfos, George Andreou, Alexandros Sianou, Argiri Sigala, Fragiska Zografos, George Filis, Konstantinos |
author_facet | Tsachiridi, Maria Galyfos, George Andreou, Alexandros Sianou, Argiri Sigala, Fragiska Zografos, George Filis, Konstantinos |
author_sort | Tsachiridi, Maria |
collection | PubMed |
description | PURPOSE: The use of platelet-rich plasma (PRP) for the treatment of nonhealing ulcers is a relatively new technique. Although it seems to result in a satisfying level of healing and low complication rates, data regarding its effectiveness remain sparse. This study aims to evaluate the potential therapeutic effects of PRP on chronic nonhealing ulcers. MATERIALS AND METHODS: This was a prospectively designed study comparing outcomes between patients treated with PRP (Group A, n=15) and patients treated conventionally (Group B, n=12) for different types of nonhealing ulcers. In Group A, PRP was produced from the patients’ own peripheral blood samples and was applied on the ulcer once every week. In Group B, patients were treated conventionally, without applying PRP. The total treatment period was 5 weeks. RESULTS: Both groups were similar regarding age, sex, comorbidities, and time of treatment. In Group A, patients showed a nonsignificant reduction of 4.5 mm(2) in ulcer area (P=0.190) and a reduction of more than 1 mm in depth (P=0.0006), while Group B showed an increase of 108±80.5 mm(2) in ulcer area after 5 weeks (P=0.016). The healing rate (HR) in Group A was stable and positive throughout the treatment period, while HR in Group B was initially negative but became positive after the 3rd week. CONCLUSION: PRP application once a week promotes the healing of chronic ulcers. It improves the ulcer’s depth and HR, although its effect on ulcer area seems to be nonsignificant. However, larger comparative series are still needed to confirm these findings. |
format | Online Article Text |
id | pubmed-6453601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Vascular Specialist International |
record_format | MEDLINE/PubMed |
spelling | pubmed-64536012019-04-16 Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study Tsachiridi, Maria Galyfos, George Andreou, Alexandros Sianou, Argiri Sigala, Fragiska Zografos, George Filis, Konstantinos Vasc Specialist Int Original Article PURPOSE: The use of platelet-rich plasma (PRP) for the treatment of nonhealing ulcers is a relatively new technique. Although it seems to result in a satisfying level of healing and low complication rates, data regarding its effectiveness remain sparse. This study aims to evaluate the potential therapeutic effects of PRP on chronic nonhealing ulcers. MATERIALS AND METHODS: This was a prospectively designed study comparing outcomes between patients treated with PRP (Group A, n=15) and patients treated conventionally (Group B, n=12) for different types of nonhealing ulcers. In Group A, PRP was produced from the patients’ own peripheral blood samples and was applied on the ulcer once every week. In Group B, patients were treated conventionally, without applying PRP. The total treatment period was 5 weeks. RESULTS: Both groups were similar regarding age, sex, comorbidities, and time of treatment. In Group A, patients showed a nonsignificant reduction of 4.5 mm(2) in ulcer area (P=0.190) and a reduction of more than 1 mm in depth (P=0.0006), while Group B showed an increase of 108±80.5 mm(2) in ulcer area after 5 weeks (P=0.016). The healing rate (HR) in Group A was stable and positive throughout the treatment period, while HR in Group B was initially negative but became positive after the 3rd week. CONCLUSION: PRP application once a week promotes the healing of chronic ulcers. It improves the ulcer’s depth and HR, although its effect on ulcer area seems to be nonsignificant. However, larger comparative series are still needed to confirm these findings. Vascular Specialist International 2019-03 /pmc/articles/PMC6453601/ /pubmed/30993104 http://dx.doi.org/10.5758/vsi.2019.35.1.22 Text en Copyright © 2019, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Tsachiridi, Maria Galyfos, George Andreou, Alexandros Sianou, Argiri Sigala, Fragiska Zografos, George Filis, Konstantinos Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study |
title | Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study |
title_full | Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study |
title_fullStr | Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study |
title_full_unstemmed | Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study |
title_short | Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study |
title_sort | autologous platelet-rich plasma for nonhealing ulcers: a comparative study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453601/ https://www.ncbi.nlm.nih.gov/pubmed/30993104 http://dx.doi.org/10.5758/vsi.2019.35.1.22 |
work_keys_str_mv | AT tsachiridimaria autologousplateletrichplasmafornonhealingulcersacomparativestudy AT galyfosgeorge autologousplateletrichplasmafornonhealingulcersacomparativestudy AT andreoualexandros autologousplateletrichplasmafornonhealingulcersacomparativestudy AT sianouargiri autologousplateletrichplasmafornonhealingulcersacomparativestudy AT sigalafragiska autologousplateletrichplasmafornonhealingulcersacomparativestudy AT zografosgeorge autologousplateletrichplasmafornonhealingulcersacomparativestudy AT filiskonstantinos autologousplateletrichplasmafornonhealingulcersacomparativestudy |